carbon monoxide and Anxiety Disorders
carbon monoxide has been researched along with Anxiety Disorders in 7 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Anxiety Disorders: Persistent and disabling ANXIETY.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Results from this study will inform FDA on the potential effects of regulating the nicotine content of cigarettes and help determine whether smokers with mood and/or anxiety disorders can safely transition to significantly reduced nicotine content cigarettes." | 9.24 | A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. ( Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J, 2017) |
"In this case report, a 40-year-old male with a past medical history of depression, anxiety, panic attacks, and substance use disorder developed symptomatic, acute carbon monoxide poisoning secondary to heavy cigarette smoking in a confined space." | 7.91 | Acute Carbon Monoxide Poisoning Secondary to Cigarette Smoking in a 40-Year-Old Man: A Case Report. ( Aloi, J; Neilsen, BK; Sharma, A, 2019) |
"Results from this study will inform FDA on the potential effects of regulating the nicotine content of cigarettes and help determine whether smokers with mood and/or anxiety disorders can safely transition to significantly reduced nicotine content cigarettes." | 5.24 | A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. ( Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J, 2017) |
"In this case report, a 40-year-old male with a past medical history of depression, anxiety, panic attacks, and substance use disorder developed symptomatic, acute carbon monoxide poisoning secondary to heavy cigarette smoking in a confined space." | 3.91 | Acute Carbon Monoxide Poisoning Secondary to Cigarette Smoking in a 40-Year-Old Man: A Case Report. ( Aloi, J; Neilsen, BK; Sharma, A, 2019) |
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors
Authors | Studies |
---|---|
Pałasz, A | 1 |
Menezes, IC | 1 |
Worthington, JJ | 1 |
Neilsen, BK | 1 |
Aloi, J | 1 |
Sharma, A | 1 |
Furlanetto, KC | 1 |
Mantoani, LC | 1 |
Bisca, G | 1 |
Morita, AA | 1 |
Zabatiero, J | 1 |
Proença, M | 1 |
Kovelis, D | 1 |
Pitta, F | 1 |
Capron, DW | 1 |
Norr, AM | 1 |
Allan, NP | 1 |
Schmidt, NB | 1 |
Allen, SI | 1 |
Foulds, J | 1 |
Pachas, GN | 1 |
Veldheer, S | 1 |
Cather, C | 1 |
Azzouz, N | 1 |
Hrabovsky, S | 1 |
Hameed, A | 1 |
Yingst, J | 1 |
Hammett, E | 1 |
Modesto, J | 1 |
Krebs, NM | 1 |
Zhu, J | 1 |
Liao, J | 1 |
Muscat, JE | 1 |
Richie, J | 1 |
Evins, AE | 1 |
Reiman, EM | 1 |
Raichle, ME | 1 |
Robins, E | 1 |
Butler, FK | 1 |
Herscovitch, P | 1 |
Fox, P | 1 |
Perlmutter, J | 1 |
Shear, MK | 1 |
Clinical Trials (2)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Association of Cigarette Smoking on Exercise Capacity and Skeletal Muscle Function in Taiwan Adult Smokers[NCT04688177] | 52 participants (Actual) | Observational | 2020-12-03 | Completed | |||
Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders[NCT01928758] | 245 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Abstinence From Smoking
Smokers assigned to reduced nicotine content cigarettes will be more likely to successfully abstain from smoking at the end of the trial, based on all randomized participants, defined as no cigarette use in past 7 days, verified by exhaled carbon monoxide <10ppm. (NCT01928758)
Timeframe: Follow-up appointment 30 weeks after randomization (12 weeks after last visit of randomized trial phase).
Intervention | Participants (Count of Participants) |
---|---|
Reduced Nicotine Content Cigarettes | 17 |
Usual Nicotine Content Cigarettes | 4 |
Intention to Quit Smoking
Smokers assigned to the reduced nicotine content cigarette group may have lower perceived dependence and be more likely to report intention to quit smoking (NCT01928758)
Timeframe: At end of 18-week randomized trial phase
Intervention | Participants (Count of Participants) |
---|---|
Reduced Nicotine Content Cigarettes | 33 |
Usual Nicotine Content Cigarettes | 25 |
Minnesota Nicotine Withdrawal Scale
This 8-item scale measures nicotine withdrawal symptoms and the scale range is from 0-32. Higher scores indicate higher severity. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
Intervention | score on a scale (Mean) |
---|---|
Reduced Nicotine Content Cigarettes | 8.1 |
Usual Nicotine Content Cigarettes | 9.0 |
Perceived Stress Scale
10-item questionnaire measuring the degree to which life situations are appraised stressful. Scale range is 0-40. Higher scores indicate more stress. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
Intervention | score on a scale (Mean) |
---|---|
Reduced Nicotine Content Cigarettes | 15.0 |
Usual Nicotine Content Cigarettes | 15.1 |
Plasma Cotinine Concentration
Plasma cotinine is a measure of daily nicotine exposure. Samples were measured in ng/mL. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
Intervention | ng/mL (Mean) |
---|---|
Reduced Nicotine Content Cigarettes | 82.8 |
Usual Nicotine Content Cigarettes | 259.0 |
Quick Inventory of Depressive Symptomatology
A 16-item scale on depression symptoms. The scale range is 0-27 where 0 = Least Severe and 27 = Most Severe. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
Intervention | score on a scale (Mean) |
---|---|
Reduced Nicotine Content Cigarettes | 5.5 |
Usual Nicotine Content Cigarettes | 5.3 |
Reviews
2 reviews available for carbon monoxide and Anxiety Disorders
Article | Year |
---|---|
The role of brain gaseous neurotransmitters in anxiety.
Topics: Animals; Anxiety; Anxiety Disorders; Brain; Carbon Monoxide; Gasotransmitters; Humans; Hydrogen Sulf | 2021 |
Pathophysiology of panic: a review of pharmacologic provocative tests and naturalistic monitoring data.
Topics: Anxiety Disorders; Arousal; Caffeine; Calmodulin; Carbon Monoxide; Fear; Humans; Imagination; Isopro | 1986 |
Trials
2 trials available for carbon monoxide and Anxiety Disorders
Article | Year |
---|---|
Combined "top-down" and "bottom-up" intervention for anxiety sensitivity: Pilot randomized trial testing the additive effect of interpretation bias modification.
Topics: Adolescent; Anxiety; Anxiety Disorders; Carbon Monoxide; Cognitive Behavioral Therapy; Female; Follo | 2017 |
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Me | 2017 |
Other Studies
3 other studies available for carbon monoxide and Anxiety Disorders
Article | Year |
---|---|
Acute Carbon Monoxide Poisoning Secondary to Cigarette Smoking in a 40-Year-Old Man: A Case Report.
Topics: Adult; Anxiety Disorders; Benzodiazepines; Carbon Monoxide; Carbon Monoxide Poisoning; Cigarette Smo | 2019 |
Reduction of physical activity in daily life and its determinants in smokers without airflow obstruction.
Topics: Activities of Daily Living; Adult; Anxiety Disorders; Carbon Monoxide; Comorbidity; Cross-Sectional | 2014 |
The application of positron emission tomography to the study of panic disorder.
Topics: Adult; Anxiety Disorders; Brain; Carbon Monoxide; Cerebrovascular Circulation; Fear; Female; Functio | 1986 |